Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators

Details for Australian Patent Application No. 2007212191 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Zhang, Xuqing; Sui, Zhihua

Agent Shelston IP

Pub. Number AU-B-2007212191

PCT Pub. Number WO2007/092727

Priority 60/772,026 10.02.06 US

Filing date 1 February 2007

Wipo publication date 16 August 2007

Acceptance publication date 22 December 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61K 31/4188 (2006.01)

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/092727 Priority application(s): WO2007/092727

22 December 2011 Application Accepted

  Published as AU-B-2007212191

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007212192-Patch-sized fluid delivery systems and methods

2007212185-Vitamin D analog - RAK, methods and uses thereof